Innovative Clinical Research, a newly launched clinical research organization, is proud to announce its official opening in Clarksville, Tennessee. With a mission of “Improving lives through science,” the company is dedicated to connecting patients with the latest advancements in medicine through clinical trials – right in their own community.
Innovative Clinical Research partners with patients to offer access to new medications and diagnostics that are often only available at major academic medical centers. By bringing these opportunities to Clarksville, the company is helping to close the gap in healthcare access and empower individuals to take part in shaping the future of medicine.
Clinical studies at no cost to patients
Patients who participate in clinical studies through Innovative Clinical Research do so at no cost. In many cases, all medical expenses are covered, and participants are compensated for their time and effort.
“We believe everyone deserves access to the most advanced medical care, no matter where they live,” said Mary Kosinski, Ph.D., founder of Innovative Clinical Research. “Our goal is to make sure patients in Clarksville have access to the same innovative treatments as those in larger cities, without having to travel.”
How Innovative Clinical Research started
The company’s roots trace back over eight years to its work within Premier Medical Group, where its experienced team built a strong foundation in clinical research. Now, as an independent organization, Innovative Clinical Research is poised to expand the scope of studies it undertakes and reach even more patients in the region.
Dr. Joseph Kosinski and Dr. Bradley Vander Veen, both seasoned primary care physicians, have a long-standing history of integrating clinical research into their medical practice. Through research, they’ve been able to bring medical advances directly to their patients and are now committed to helping other providers do the same. Their vision is to create a collaborative network where local physicians can offer cutting-edge treatments to their own patient populations – without the need to refer out to distant academic centers.
“Clinical research has allowed me to offer hope and new options to patients who had exhausted traditional treatments,” said Dr. Vander Veen, co-founder of Innovative Clinical Research. “It’s incredibly rewarding to see how these studies can improve lives, and I’m excited to help other providers bring these opportunities to their patients as well.”
How to take part in clinical studies
Innovative Clinical Research is actively enrolling patients and collaborating with physicians, sponsors, and key opinion leaders to advance clinical programs through the FDA process and bring new medical therapies to market. The team brings deep expertise across a range of therapeutic areas and is committed to maintaining the highest standards of regulatory compliance and patient care.
Call for collaboration: Innovative Clinical Research welcomes partnerships with primary care providers, specialists, nurse practitioners and physician assistants seeking to help their patients access new medical therapies. ICR focuses on fatty liver disease (MASLD/MASH), and cirrhosis and will provide free FibroScans to any patient referred to them. ICR also focuses on several other indications including; weight loss, high triglycerides, other metabolic diseases, vaccines, pediatrics and women’s health.
For more information or to schedule a free FibroScan or to learn how to participate in a clinical trial, visit the Innovative Clinical Research website, email information@ICRresearch.com or call 931-298-0336.